FOURKITES
23.8.2022 10:18:11 CEST | Business Wire | Press release
Leading real-time supply chain visibility platform FourKites ® today announces that its carrier data will be used to enhance 3T’s global digital transport platform.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220823005400/en/
The deal will give 3T’s shipper customers access to FourKites’ supply chain visibility data, bringing them powerful flexibility in the way they use carriers, thereby reducing costs and improving sustainability initiatives.
“FourKites’ broad coverage of carriers in Europe allows us to give our customers a more comprehensive shipment visibility offering as part of our digital transport management software,” says Rob Hutton, Group Sales and Marketing Director at 3T. “That gives them more flexibility in the carriers they can work with, keeping both costs and carbon emissions down.”
3T is a UK-based global SaaS digital transport platform provider, whose transport management solutions dovetail neatly with FourKites’ supply chain visibility offering. 3T’s pioneering cloud-based platform provides a seamless shipper/carrier ecosystem with functionality including transport assignment, rate management and tendering, as well as automatic carrier allocation. It also facilitates supply chain collaboration by enabling AI-driven dynamic planning and execution across multiple accounts, harnessing real-time data to reduce empty running of vehicles.
FourKites is the market leader in real-time, end-to-end supply chain visibility, extending visibility beyond transportation into yards, warehouses, stores and more. The companies’ combined offering signals a paradigm shift in 3T’s ability to not only know the status and position of every shipment, but to also dynamically react to changes from plan.
“Giving 3T customers access to FourKites data will allow them to make better decisions, optimising the way they use carriers,” says Marc Boileau, Senior VP of Sales and Carrier Operations at FourKites Europe. “That has cost benefits for them, it improves their service to customers with almost no administrative work required, and it gives them the most accurate estimated times of arrival available in the market today. We are thrilled to be working together with the 3T team to better support their customer base.”
Carbon reductions
3T already gives customers multiple options to capture carrier data. However, with the addition of FourKites’ real-time supply chain data, 3T customers will now have all the data necessary to complete their operational visibility picture and ultimately help them reduce both carbon emissions and costs through improved resource utilisation.
“We see a huge efficiency opportunity for both shippers and carriers by using data to identify and reduce empty running across the industry. This will be essential to meet our collective environmental targets,” says Rob, "and it’s why this partnership is so exciting for us.”
This is just one aspect of the improved planning shippers can achieve with the 3T-FourKites partnership.
“You’re likely to get a good price by placing a shipment on an empty running truck,” says Marc, “so costs go down. But carriers have fewer empty runs, too, so they see driver productivity improve. It’s win-win. The better your visibility, the better you can plan to optimise your transport.”
In March, FourKites announced its Sustainability Hub, which offers granular emissions tracking, industry benchmarks, analytics and scenario modeling to help customers meet sustainability goals. In addition, the company offers Dynamic Yard ® , a new category of software that connects traditional, siloed yard management software with FourKites’ real-time supply chain data and predictive ETAs to provide insight into driver detention patterns, labor efficiency and more to reduce dwell and inform carbon reduction strategies. Last year, customers who used Dynamic Yard emitted 20% fewer carbon emissions than non-Dynamic Yard users through reductions in truck idle times.
Notes for editors
About FourKites®
Leading global supply chain visibility platform FourKites® extends visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2.5 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching more than 200 countries, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,100 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit www.fourkites.com .
About 3T
3T Logistics and Technology Group is an award-winning UK head-quartered SaaS transport management technology business with clients including JCB, Klockner Pentaplast and Kraft Heinz. Founded in 2000 as a 4th Party Logistics Provider (4PL), 3T has evolved to become a globally recognised transportation management (TMS) technology provider. The company’s vision and mission remain the same since its inception, to improve service, reduce cost to shippers and carriers and remove empty running through collaboration and the smart use of technology.
To learn more about 3T please visit their website: https://www.3t-ltg.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20220823005400/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
